Loading insider details...
Beta
Latest Form 4 (Sep 2, 2026): Grant/Award of 3,000 DCOY shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 2, 2026 | Decoy Therapeutics Inc. (DCOY) | Grant/Award | 3,000 | n/a |
| Aug 28, 2026 | OMEROS CORP (OMER) | Exercise/Conversion | 5,000 | $79.0K |
| Jun 22, 2026 | OMEROS CORP (OMER) | Grant/Award | 15,000 | n/a |
| Jan 2, 2026 | Salarius Pharmaceuticals, Inc. (SLRX) | Sale | 15 | $9.60 |
| Nov 24, 2025 | Salarius Pharmaceuticals, Inc. (SLRX) | Purchase | 5,000 | $3.7K |
| Jul 1, 2025 | OMEROS CORP (OMER) | Grant/Award | 15,000 | n/a |
| Jun 7, 2024 | OMEROS CORP (OMER) | Grant/Award | 15,000 | n/a |
| Feb 22, 2024 | Salarius Pharmaceuticals, Inc. (SLRX) | Grant/Award | 20,500 | n/a |
| Jun 27, 2023 | OMEROS CORP (OMER) | Grant/Award | 15,000 | n/a |
| May 23, 2023 | OMEROS CORP (OMER) | Exercise/Conversion | 5,000 | $26.5K |